Source:http://linkedlifedata.com/resource/pubmed/id/10717326
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2000-6-23
|
| pubmed:abstractText |
Although it is commonly assumed that clinical trials are more costly than standard therapy, there have been no previous studies of the cost of conducting phase II trials in lung cancer. We retrospectively analyzed two National Cancer Institute of Canada phase II trials in previously untreated small cell lung cancer (SCLC) to determine the costs of conducting the trials in a cancer treatment centre. Both studies were clinical trials undertaken as part of the NCIC's Investigational New Drug program: IND 69 and IND 50 evaluated docetaxel (taxotere) and gemcitabine, respectively.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0169-5002
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
28
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
85-95
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:10717326-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10717326-Canada,
pubmed-meshheading:10717326-Carcinoma, Small Cell,
pubmed-meshheading:10717326-Clinical Trials, Phase II as Topic,
pubmed-meshheading:10717326-Costs and Cost Analysis,
pubmed-meshheading:10717326-Drug Costs,
pubmed-meshheading:10717326-Humans,
pubmed-meshheading:10717326-Lung Neoplasms,
pubmed-meshheading:10717326-Retrospective Studies
|
| pubmed:year |
2000
|
| pubmed:articleTitle |
An estimate of the cost of conducting phase II trials in lung cancer.
|
| pubmed:affiliation |
The Ottawa Regional Cancer Centre, 190 Melrose Avenue, Ottowa, Canada.
|
| pubmed:publicationType |
Journal Article
|